Long-term results of breast conservation therapy for breast cancer

被引:37
作者
Neff, PT
Bear, HD
Pierce, CV
Grimes, MM
Fleming, MD
Neifeld, JP
Arthur, D
Horsley, JS
Lawrence, W
Kornstein, MJ
机构
[1] VIRGINIA COMMONWEALTH UNIV, DEPT SURG, DIV SURG ONCOL, MED COLL VIRGINIA, RICHMOND, VA 23298 USA
[2] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PATHOL, RICHMOND, VA 23298 USA
[3] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT RADIAT ONCOL, RICHMOND, VA 23298 USA
[4] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, MASSEY CANC CTR, RICHMOND, VA 23298 USA
关键词
D O I
10.1097/00000658-199606000-00009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective This study was done to determine the long-term outcome of breast conservation therapy (BCT) for patients with early-stage breast cancer during a period of treatment evolution at a single institution Summary Background Data Breast cancer treatment has evolved from extensive surgical extirpation of the breast to treatment options that conserve the breast. Prospective and retrospective studies have confirmed the efficacy of BCT and justify its use for many patients with early breast cancer, but there is no universally accepted consensus as to who benefits from more aggressive application of surgery or radiotherapy in BCT. Prognostic variables for breast cancer and information on factors that contribute to local recurrence help predict BCT results. Continued analysis of BCT still is necessary to improve patient outcome. Methods Eighty-five patients treated with BCT (lumpectomy with adjuvant radiation therapy) at the Medical College of Virginia from 1980 to 1990 were identified. Clinicopathologic parameters and treatment details were analyzed for relationship to development of local recurrence, distant metastasis, and survival. Fisher's exact test was used for comparisons. Actuarial survival curves were plotted. The earlier treatment period (1980-1985) was compared with the later treatment period(1985-1990). Results Median follow-up was 5 years. Actuarial overall survival was 83% at 5 years (69% at 10 years), and 5-year distant metastasis-free survival was 79%. The 5-year actuarial local recurrence rate was 6.6% (crude rate 10.6%, 9/85). Young patients (age < 40 years) were found to be at increased risk for local recurrence (24% < 40 years vs. 6% greater than or equal to 40 years, p < 0.05). Tumor margins less than or equal to 3 mm were more frequently found, and lumpectomy site radiation boost was used increasingly from 1986 to 1990. Almost half of all local recurrences occurred after 5 years. conclusions Survival and local recurrence rates were comparable to other series. Young patients were found to be at increased risk for local recurrence. Negative microscopic margins, even when close, can provide low local recurrence rates when adjuvant radiation therapy is administered.
引用
收藏
页码:709 / 716
页数:8
相关论文
共 31 条
[1]   LOCAL FAILURE AND MARGIN STATUS IN EARLY-STAGE BREAST-CARCINOMA TREATED WITH CONSERVATION SURGERY AND RADIATION-THERAPY [J].
ANSCHER, MS ;
JONES, P ;
PROSNITZ, LR ;
BLACKSTOCK, W ;
HEBERT, M ;
REDDICK, R ;
TUCKER, A ;
DODGE, R ;
LEIGHT, G ;
IGLEHART, JD ;
ROSENMAN, J .
ANNALS OF SURGERY, 1993, 218 (01) :22-28
[2]  
BORGEN PI, 1995, CURR PROB SURG, V32, P193
[3]   RISK-FACTORS IN BREAST-CONSERVATION THERAPY [J].
BORGER, J ;
KEMPERMAN, H ;
HART, A ;
PETERSE, H ;
VANDONGEN, J ;
BARTELINK, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :653-660
[4]   LOCAL-CONTROL AND SURVIVAL OF BREAST-CANCER TREATED BY LIMITED SURGERY FOLLOWED BY IRRADIATION [J].
CALLE, R ;
VILCOQ, JR ;
ZAFRANI, P ;
VIELH, P ;
FOURQUET, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (06) :873-878
[5]   REANALYSIS AND RESULTS AFTER 12 YEARS OF FOLLOW-UP IN A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER [J].
FISHER, B ;
ANDERSON, S ;
REDMOND, CK ;
WOLMARK, N ;
WICKERHAM, DL ;
CRONIN, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1456-1461
[6]   8-YEAR RESULTS OF A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY AND LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER [J].
FISHER, B ;
REDMOND, C ;
POISSON, R ;
MARGOLESE, R ;
WOLMARK, N ;
WICKERHAM, L ;
FISHER, E ;
DEUTSCH, M ;
CAPLAN, R ;
PILCH, Y ;
GLASS, A ;
SHIBATA, H ;
LERNER, H ;
TERZ, J ;
SIDOROVICH, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (13) :822-828
[7]  
FISHER ER, 1992, SEMIN SURG ONCOL, V8, P161
[8]   10 YEAR RESULTS OF CONSERVATIVE SURGERY AND IRRADIATION FOR STAGE-I AND STAGE-II BREAST-CANCER [J].
FOWBLE, BL ;
SOLIN, LJ ;
SCHULTZ, DJ ;
GOODMAN, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (02) :269-277
[9]  
HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391
[10]   LOCOREGIONAL RECURRENCE OF BREAST-CANCER - A RETROSPECTIVE COMPARISON OF IRRADIATION ALONE VERSUS IRRADIATION AND SYSTEMIC THERAPY [J].
HALVERSON, KJ ;
PEREZ, CA ;
KUSKE, RR ;
GARCIA, DM ;
SIMPSON, JR ;
FINEBERG, B .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (02) :93-101